163 related articles for article (PubMed ID: 30766887)
1. The Relevance of Assessing the Cell Proliferation Factor Ki-67 in Squamous Cell Carcinoma of the Larynx.
Vukelic J; Dobrila-Dintinjana R; Dekanic A; Marijic B; Cubranic A; Braut T
Biomed Res Int; 2019; 2019():8142572. PubMed ID: 30766887
[TBL] [Abstract][Full Text] [Related]
2. [The expression of ki-67, topoIIalpha in laryngeal squamous cell carcinoma].
Deng G; Yang C; Chen W
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 May; 19(9):396-8. PubMed ID: 16075972
[TBL] [Abstract][Full Text] [Related]
3. Correlation between levels of expression of minichromosome maintenance proteins, Ki-67 proliferation antigen and metallothionein I/II in laryngeal squamous cell cancer.
Nowinska K; Chmielewska M; Piotrowska A; Pula B; Pastuszewski W; Krecicki T; Podhorska-Okołow M; Zabel M; Dziegiel P
Int J Oncol; 2016 Feb; 48(2):635-45. PubMed ID: 26648405
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical staining of Ki-67 using the monoclonal antibody Ki-s11 is a prognostic indicator for laryngeal squamous cell carcinoma.
Cordes C; Münzel AK; Rudolph P; Hoffmann M; Leuschner I; Gottschlich S
Anticancer Res; 2009 Apr; 29(4):1459-65. PubMed ID: 19414402
[TBL] [Abstract][Full Text] [Related]
5. Prognostic relevance of the proliferation marker REPP86 for laryngeal cancer.
Cordes C; Münzel AK; Görögh T; Leuschner I; Ambrosch P; Gottschlich S; Hoffmann M
Anticancer Res; 2010 Sep; 30(9):3541-7. PubMed ID: 20944135
[TBL] [Abstract][Full Text] [Related]
6. Expression of topoisomerase II alpha, Ki-67 and p53 in early stage laryngeal carcinomas not featuring vocal cord fixation.
Horibe Y; Murakami M; Komori K; Imaeda Y; Kasahara M
APMIS; 2000 Oct; 108(10):689-96. PubMed ID: 11200824
[TBL] [Abstract][Full Text] [Related]
7. MIB-1 and involucrin expression in laryngeal squamous carcinoma: the relationship to host and tumour factors and survival.
Roland NJ; Rowley H; Scraggs M; Johnson P; Jones AS
Clin Otolaryngol Allied Sci; 1996 Oct; 21(5):429-38. PubMed ID: 8932948
[TBL] [Abstract][Full Text] [Related]
8. Ki-67 immunostaining and prognosis in laryngeal cancer.
Krecicki T; Jeleń M; Zalesska-Krecicka M; Szkudlarek T
Clin Otolaryngol Allied Sci; 1998 Dec; 23(6):539-42. PubMed ID: 9884809
[TBL] [Abstract][Full Text] [Related]
9. p63 and Ki-67 immunostainings in laryngeal squamous cell carcinoma are related to survival.
Re M; Zizzi A; Ferrante L; Stramazzotti D; Goteri G; Gioacchini FM; Olivieri F; Magliulo G; Rubini C
Eur Arch Otorhinolaryngol; 2014 Jun; 271(6):1641-51. PubMed ID: 24402377
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor receptor (EGFR), proliferating cell nuclear antigen (PCNA) and Ki-67 antigen in laryngeal epithelial lesions.
Krecicki T; Jeleń M; Zalesska-Krecicka M; Rak J; Szkudlarek T; Jeleń-Krzeszewska J
Oral Oncol; 1999 Mar; 35(2):180-6. PubMed ID: 10435153
[TBL] [Abstract][Full Text] [Related]
11. Ki-67 (MIB1), p53, and Lewis-X (LeuM1) as prognostic factors of recurrence in T1 and T2 laryngeal carcinoma.
Sittel C; Eckel HE; Damm M; von Pritzbuer E; Kvasnicka HM
Laryngoscope; 2000 Jun; 110(6):1012-7. PubMed ID: 10852523
[TBL] [Abstract][Full Text] [Related]
12. Retrospective analysis of Ki-67 antigen expression in paraffin tissue blocks of laryngeal squamous cell carcinoma.
Fumic-Dunkic L; Katic V; Janjanin S; Klapan I; Simuncic A; Vcev A
Am J Otolaryngol; 2003; 24(2):106-10. PubMed ID: 12649825
[TBL] [Abstract][Full Text] [Related]
13. The clinical relevance of Ki-67 expression in laryngeal squamous cell carcinoma.
Gioacchini FM; Alicandri-Ciufelli M; Magliulo G; Rubini C; Presutti L; Re M
Eur Arch Otorhinolaryngol; 2015 Jul; 272(7):1569-76. PubMed ID: 24890978
[TBL] [Abstract][Full Text] [Related]
14. MCM-2, Ki-67, and EGFR downregulated expression levels in advanced stage laryngeal squamous cell carcinoma.
Vivatvakin S; Ratchataswan T; Leesutipornchai T; Ruangritchankul K; Keelawat S; Mahattanasakul P; Bongsebandhu-Phubhakdi S
Sci Rep; 2021 Jul; 11(1):14607. PubMed ID: 34272446
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of p27Kip1 expression in Basaloid Squamous Cell Carcinoma of the larynx.
Salerno G; Di Vizio D; Staibano S; Mottola G; Quaremba G; Mascolo M; Galli V; De Rosa G; Insabato L
BMC Cancer; 2006 Jun; 6():146. PubMed ID: 16740156
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of the proliferation marker Ki-67 in laryngeal carcinoma: results of the accelerated radiotherapy with carbogen breathing and nicotinamide phase III randomized trial.
Rademakers SE; Hoogsteen IJ; Rijken PF; Terhaard CH; Doornaert PA; Langendijk JA; van den Ende P; van der Kogel AJ; Bussink J; Kaanders JH
Head Neck; 2015 Feb; 37(2):171-6. PubMed ID: 24347430
[TBL] [Abstract][Full Text] [Related]
17. Standardised Ki-67 proliferation index assessment in early-stage laryngeal squamous cell carcinoma in relation to local control and survival after primary radiotherapy.
Kop E; de Bock GH; Noordhuis MG; Slagter-Menkema L; van der Laan BFAM; Langendijk JA; Schuuring E; van der Vegt B
Clin Otolaryngol; 2020 Jan; 45(1):12-20. PubMed ID: 31561282
[TBL] [Abstract][Full Text] [Related]
18. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
Ioachim E; Peschos D; Goussia A; Mittari E; Charalabopoulos K; Michael M; Salmas M; Vougiouklakis T; Assimakopoulos D; Agnantis NJ
J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus and Epstein-Barr virus infection, p53 expression, and cellular proliferation in laryngeal carcinoma.
de Oliveira DE; Bacchi MM; Macarenco RS; Tagliarini JV; Cordeiro RC; Bacchi CE
Am J Clin Pathol; 2006 Aug; 126(2):284-93. PubMed ID: 16891205
[TBL] [Abstract][Full Text] [Related]
20. [Expression of Ki-67 and p53 in laryngeal squamous cell carcinomas].
Calli C; Calli A; Pinar E; Oncel S; Demirtaşoğlu F
Kulak Burun Bogaz Ihtis Derg; 2005; 15(1-2):9-13. PubMed ID: 16340285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
